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Introduction
Skin cancer in the United States is a large and growing public health concern

with an estimated one million new cases diagnosed each year. As a result, there are

many modalities available for use in prevention and treatment. The efficacy of natural
alternatives to prevent and treat skin cancer has become an area of great interest that is

relatively unknown to physicians. Despite this, the US population has embraced

complementary medicine alternatives, often as a replacement for traditional allopathic
therapies, in many areas including skin cancer. For public health advocates,

knowledge of the effectiveness of these alternative therapies and the evidence that
support these remedies is essential.
This paper will discuss the scope of the skin cancer problem in the US

including epidemiology and current methods of screening and prevention. Following
this will be an extensive review of the most current information regarding the

prevention and treatment of skin cancer through dietary modification and topical
application of antioxidants, vitamins, and herbal supplements. The results of placebocontrolled randomized clinical trails, large human cohort studies and case-control
studies have been emphasized to provide an evidence-based approach toward

improving the health of our population.

Epidemiology of Skin Cancer

Incidence

Of the three major types of skin cancer, basal cell carcinoma (BCC) accounts
for approximately 80%, squamous cell carcinoma (SCC) for approximately 16%, and
cutaneous malignant melanoma (MM) for approximately 4%.

Of skin cancer deaths,

however, nearly 90% result from malignant melanoma. On average in the United

States, one person dies of melanoma every hour. Early detection and education are

levering-off or decreasing the incidence, morbidity, and mortality rates of all forms of
skin cancer.

Malignant Melanoma was the sixth most common cause of new cancer cases in
the United States for 1999 among males and seventh among females, accounting for

4% and 3%, respectively. 2 In the United States, MM is more common than any
noncutaneous cancer among 25-29 year olds. Epidemiologic data is more precise for

MM than nonmelanoma skin cancer (NMSC) because the diagnosis of the former but
not the latter is routinely reported to tumor registries. 3

Marked increases in the incidence of MM occurred from the mid-1960s to the
mid-1990s. It has been estimated that the incidence in Caucasians increased from 3%
to 7% during this 30-year period. 4 Calculations based on data from the Surveillance,

Epidemiology, and End Results (SEER) program of the National Cancer Institute,
showed an increase in the incidence of MM in the United States of 120.5% from 1973
to 1994. However, increased education and awareness appear to result in earlier

detection and a greater increase in thin rather than thick tumors. In the United States,

a 500% increase from the period of 1973-77 to 1983-87 was reported in the diagnosis

of in situ MM compared to a 52% increase in the diagnosis of invasive MM. 6
Stabilization or decrease of incidence rates of MM have been reported over

the past few years. For example, in the United States from 1990 to 1994, rates
stabilized or declined for females younger than 60 years old and males younger than

50 years old, while rates increased for older age groups, s The incidence in the United

States of invasive tumors decreased two consecutive years from 14.1 per 100,000 in
1991 to 13.8 per 100,000 in 1993. 6

Risk Factors
Skin cancer is exceedingly more common in Caucasians than other races,

although NMSC not infrequently affects Hispanics and acral lentiginous melanoma is
the most common type of MM affecting Asians and blacks. All forms of skin cancer
are more common in men than women. NMSC most commonly affects chronically

sun-exposed sites including the head and neck, trunk, and upper extremities. MM
most commonly affects sites of intermittent intense sun exposure, the trunk in men and

the lower extremity in women. Risk factors for skin cancer include history of

significant sun exposure; light colored eyes, skin, and hair; tendency to sunburn easily
and tan poorly; personal or family history of skin cancer; male sex; advancing age;
and immunodeficiency, resulting from status post organ transplantation or human

immunodeficiency virus infection. There are additional unique risk factors for the

development of MM such as a personal history of atypical moles or multiple moles.

Prognosis

The prognosis for BCC is excellent. Only 0.0028% of BCCs metastasize.
Metastatic disease is more common in men than women and usually arises from large

neglected tumors. Five year survival for metastatic BCC is less than 33%. 7 Patients
with basal cell nevus syndrome, a rare sporadic or autosomal dominant condition

characterized by multiple BCCs, jaw cysts, palmoplantar pits, and a wide variety of

other anomalies, may develop locally invasive or metastatic tumors.

Approximately 5% of SCCs metastasize within 5 years. Risk factors for
metastases include depth greater than 4 mm; diameter greater than 2 cm; poorly

differentiated histology; perineural, vascular, and lymphatic invasion; tumors located
on the lip; tumors arising in osteomyelotic foci, bums, and scars; immunodeficiency.

Five year survival is approximately 30% for patients with metastatic SCC. 7 In 1998,

there were approximately 1,200 deaths from SCC.

In the United States, nearly 90% of skin cancer deaths are from MM and 7,300
deaths from MM were estimated for 1999. Mortality rates for MM rose 38.9% from
1973 to 1994. s Mortality rates are greater for males than for females and for older

than younger individuals. Mortality rates stabilized or decreased for all groups from

1990-94, except for men 70 years or older and women 60-69 years old. s Thicker
tumors are associated with greater risk for advanced disease and mortality. Five year

survival is 93-100% for tumors < 0.76 mm in depth and 50% or less for tumors > 4
mm. 8 For the period from 1989 to 1994, the five year survival for CMM in the United

States was 88% for white patients and 69% for black patients. 2

Traditional Methods of Skin Cancer Prevention

Primary prevention of skin cancer involves education of the population to

actively attempt to reduce the amount of their ultraviolet exposure. This includes the
use of daily sunscreen application and the use of clothing and hats to prevent

unnecessary sunlight exposure. Secondary prevention involves early detection of

changes in the skin through specific screening methods to decrease morbidity and
mortality of skin cancer.
Since BCC is so rarely fatal, early detection impacts insignificantly on

mortality. However, early diagnosis of BCC is effective in minimizing local tissue
destruction by the tumor and allows for less complex surgical excision of the tumor,

decreased size of the surgical defect, and improved cosmesis. Similarly, early
detection of SCC reduces morbidity of the disease. Additionally, early detection of

SCC is likely to be associated with decreased risk for regional and distant metastatic
disease and improved mortality rates.

Early detection of MM is considered essential because of the high mortality
rate and the strong relationship between tumor thickness and mortality. MMs

diagnosed during periodic surveillance examinations are more likely to be smaller and
thinner than those diagnosed at first presentation. 9 Skin self-examination has been

suggested to reduce the mortality by 63% by reducing the incidence of CMM and the
risk of advanced disease.

Physical examination of the skin is the method by which individuals are

screened for skin cancer. Biopsy submitted to a dermatopathology laboratory is

essential for histologic confirmation of suspicious lesions. History of risk factors for
skin cancer and of new, changing, or symptomatic lesions aids the screening process.

Total body photography of patients with atypical and/or multiple melanocytic nevi,

epiluminescence microscopy, and computerized digital imaging are tools the

subspecialist may utilize as adjuncts to the physical examination. Detection in the
peripheral blood of biochemical markers for CMM is an experimental technique which

may be most useful in identifying advanced tumors and predicting response to medical

therapy l

Mechanisms of Skin Cancer Development

The biochemical mechanisms responsible for cell injury and cell death are

complicated and the pathways are multiple and overlapping. We will focus on the
roles played by two major contributors to cellular damage, oxygen-derived free
radicals and ultraviolet radiation, in mediating the pathological changes manifested

clinically as NMSC and melanoma.

Reactive Oxygen Species

With a single unpaired electron in their outer orbit, free radicals or reactive

oxygen species (ROS) are highly unstable chemical species that can damage lipids,
proteins, and nucleic acids. Free radicals also initiate autocatalytic reactions that
convert the molecules they interact with into additional free radicals, lz Reactive

oxygen species can be generated within cells as a byproduct of mitochondrial

respiration in the reduction of molecular oxygen to water, the absorption of ultraviolet
light, and the donation or acceptance of free electrons by transitional metals. These

processes generate hydrogen peroxide, superoxide anion radicals, and hydroxyl ions.
Nitric oxide (NO), an important chemical mediator produced by endothelial cells,

macrophages, and neurons, can also act as free radicals. NO can be converted to
highly reactive species such as the peroxynitrite anion (ONOO), NO2 and NOCellular damage occurs when free radicals, in the presence of oxygen, attack

membrane lipids yielding peroxides, which serve as autocatalytic propagators of free
radical reactions.

Cells have an endogenous defense system to combat free radical induced
cellular damage and death. There is a delicate balance between the generation of free
radicals and the free radical scavenging systems. As unstable chemical species, many

free radicals decay spontaneously. Additionally, there are several enzymatic and non-

enzymatic pathways that help to deactivate these reactive oxygen species. Free
radicals such as hydrogen peroxide, superoxide, and hydroxyl radicals are detoxified

by catalase, superoxide dismutase, and glutathione peroxidase, respectively. The nonenzymatic pathway includes antioxidants such as vitamins that neutralize free radicals.

When free radical formation exceeds free radical termination, cells experience
oxidative stress leading to pathological transformation.

Ultraviolet Radiation

The two major pathological effects of ultraviolet radiation are photodamage

leading to premature aging of the skin and skin cancer. It has been postulated that
ultraviolet carcinogenesis consists of two events: first, the transformation of a skin cell
to a neoplastic form and second, UVB-induced immunosuppression. 4 Ultraviolet

radiation, specifically UVB, can cause direct damage to DNA such as the formation of
pyrimidine dimers between adjacent pyrimidine bases on the same DNA strand,
single-stranded breaks, and DNA-protein cross links3o UV radiation also causes
mutations in oncogenes, such as ras, and tumor suppressor genes, such as p53. The
ras family of proto-oncogenes mediates cell-signaling pathways for many growth

factor receptors. 5 Ras may play an important role in early skin carcinogenesis as

UVB rays have caused "signature mutations" in ras genes in some human basal cell

carcinomas (BCCs).

The tumor suppressor gene p53 serves as a filter for cells that

have acquired mutations in the skin. The p53 gene conveys its tumor suppressive

effects by initiating apoptosis of mutated progeny cells. s Following exposure to UV
s
radiation there is a transient increase in p53 levels in the skin. The elimination of

mutated keratinocytes via the p53 apoptotic pathway prevents the formation of
mutated keratinocyte cell colonies. This inducible reparative ability may be due to the

DNA fragment thymidine dinucleotide. This DNA fragment has been shown to
increase the rate of repair of DNA ultraviolet damage by 2 or 3 fold. 6 It is thought

that the induction of DNA repair mechanisms is related to the up regulation of the
tumor suppressor gene p53. Cutaneous levels of p53 continue to persist several days

after UV exposure. 6 When the p53 gene becomes mutated, as a result of UVB

exposure, cells fail to undergo programmed cell death is Indeed, squamous cell
carcinomas have been found to have a high percentage of p53 mutations. 7

Additionally, UV radiation has been linked to cutaneous immunosuppression

resulting in both a decrease in surveillance for UV induced tumor antigens and

depressed cell mediated contact hypersensitivity response (CHS). Animal studies
have shown that UV radiation exposure, prior to the application of known topical

mutagens such as dinitrochlorobenzene (DNCB), decreases the normal skin response
to the DNCB antigen. This subdued response includes a decrease in skin erythema,

edema, and induration at the site of application for 2 to 3 days. 15 It is thought that this
immune reaction may be a result of the UV induced disturbance of the communication

between the antigen presenting cells of the skin, the Langerhans cells, and antigen

specific T-lymphocytes. is

Dietary and Topical Antioxidant Effects on NMSC
Retinoids

The term retinoid encompasses both naturally occurring molecules that are
present in low levels in the peripheral blood and also synthetically derived compounds
with biological activities of vitamin A or retinol. Natural sources of vitamin A include

liver, egg yolk, butter, fish, yellow and orange fruits and vegetables including carrots,

tomatoes, apricots, and cantaloupe and green leafy vegetables. Vitamin A and its
metabolic derivatives, retinaldehyde and retinoic acid, are fat-soluble molecules

necessary for growth, differentiation, and maintenance of epithelial tissues.
Retinoids can be thought of as both vitamins and hormones. They are vitamins

in that retinol is not synthesized from the body and must be obtained through the diet

and they are hormones in that the body transforms retinol into substrates (9-cis RA

and tRA) which bind to nuclear receptors and serve as signaling molecules to regulate

epithelial cell differentiation, proliferation, growth, and metabolism. 9 Cell growth,
proliferation, differentiation and cell death are influenced by DNA transcription via
the binding of retinoids to both the retinoi.d acid receptors (RARs) and the retinoid X

receptors (RXRs).

In order to decrease the toxic effects of vitamin A and utilize its more
biologically active components, the naturally occurring molecule must be modified for

therapy.

Three classes of synthetic retinoids are used today which include"

nonaromatic retinoids such as tretinoin and isotretinoin, monoaromatic retinoids such

10

11

as etretinate and acitretin, and polyaromatic retinoids such as adapalene and

tazarotene. 21

Two cell line studies by Moon et al. in 1983 and 1992z’23 have shown the
influence retinoids have on cell growth and differentiation and their suppressive

effects on carcniogenesis of epithelial rumors and other cancer cell lines. Earlier
studies involving the chemoprotective effects of retinoids in mice and human clinical

reports emphasized their effectiveness for the prevention of chemical and UV light
induced skin cancer. 24’25’26 Unfortunately, the human clinical studies consisted of

small sample populations and the high doses of retinoids used had significant side

effects. 27 Larger studies involving oral administration of lower doses of retinoids

(isotretinoin) resulted in poor chemoprevention against BCCs. 28 Subsequently,
retinoids have been more extensively studied in the chemoprevention of NMSC.

Moon et al., 199729 conducted a randomized placebo-controlled 5 year clinical
trial which examined the use of vitamin A (25,000 U) vs. placebo in 2,297 patients

with a moderate risk of skin cancer development (i.e., a history of > 10 actinic

keratoses but fewer than 3 BCCs or SCCs). They found that patients who were treated
with vitamin A had fewer SCCs than the placebo group; however, this was not the
case for BCCs.

Several cohort and case-control studies have been undertaken during the last 5

years to examine the relationship between retinoids and chemoprevention. The van

Dam et al. 200030 study, in which a large prospective cohort of men was evaluated in
terms of the relationship between their respective diets and their subsequent

development of BCC, did not show a significant difference between those individuals
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that consumed higher amounts of retinols in their diet than those who did not. This

199731

finding is consistent with other large randomized trials including Levine et al.

in which 400 subjects with a previous history of 4 or more skin cancers were treated
with isotretinoin 10-15mg/day, vitamin A 25,000 U, or placebo. No significant

difference between the treatment groups or controls was detected. T-hese studies both

support the evidence obtained by Tangrea et al.,

199228 whose multicenter study

examining the possible benefit of low dose isotretinoin (10mg/day vs. placebo for 3

years) on the prevention of BCC showed no difference between the study groups.

In addition to these larger best evidence studies, several smaller trials have
illustrated the potential role of oral retinoids in the prevention of NMSC. 32’3

However, the most significant results were seen in niche treatment protocols for
patients with a higher susceptibility to skin neoplasms. For example, patients with
xeroderma pigmentosum treated with isotretinoin for 2 years had an average reduction
of 63% in the number of skin cancers over a 2-year period as compared to no previous

treatment. 33 More recently, however, DiGiovanna

199834 studied whether isotretinoin

could be effective in chemoprevention of skin cancer in high-risk patients with

xeroderma pigmentosum. A small sample of patients (of 7 patients enrolled, 5 were
able to complete the study) used isotretinoin at 2mg/kg/day for 2 years. He found that
there was a 63% reduction in the number of cancers these patients developed as

compared with the 2 years prior to therapy. However, upon discontinuation of
isotretinoin therapy, skin neoplasms developed within 2 to 3 months. These findings

suggest that the chemopreventive effect of isotretinoin is limited to the active
treatment period.
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The development of skin cancer in immunosuppressed individuals after

transplantation is particularly significant in areas of the world with high levels of
ultraviolet exposure. As medical technology rapidly advances, organ transplantation

and sustained immune suppression is increasingly more common. Incidences of

NMSC in renal transplant recipients in Australia increased exponentially over a >9
year period" 3% within the first year, 25% at 5 years and 44% at 9 or more years. 34’35
The use of retinoids as a preventative therapy for transplant recipients has been

explored in several studies. For example, Bavinck et al., 1995 6 conducted a doubleblind placebo controlled study in which acitretin 30mg/day or placebo pills were given
to 38 renal transplant recipients for 6 months. The patients who received the acitretin

developed significantly fewer SCCs than the placebo group alone (P=0.01), suggesting
that acitretin may offer a chemoprotective effect against skin neoplasms.

Small studies have also been undertaken to examine the combined therapeutic
effect of isotretinoin and calcitriol to treat and prevent multiple early NMSCs.
Calcitriol (0.5 to 1.0 ug/kg/day) and isotretinoin (0.3 to 0.5 mg/kg/day) were given to

11 patients over a 15-month period. The authors reported a decrease in the size of
most of the actinic kerotoses of the 11 patients and a decrease in size of an early SCC

in one patient. 7 This study was both small and without placebo controls so its results

may be due to chance alone. The data suggest, however, that the use of synergistic
vitamin derivatives may offer possible future tumor prevention if a larger number of

patients and a placebo-controlled methodology is employed.
The induction of multiple squamous cell carcinomas following long term

PUVA treatments for psoriasis has been well established. 8’9 It has been proposed
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that combination therapy of retinoids and PUVA may reduce the risk of skin cancer
and other skin damage associated with PUVA treatment. 4 Acitretin, the active
metabolite of etretinate, has recently been approved in this country for the treatment of

psoriasis. As a monotherapy, acitretin is an effective method for treatment of pustular
and erythrodermic psoriasis but for plaque psoriasis, it is best used as an adjuvant

therapy with UVB or with PUVA. 4 Combining acitretin with PUVA results in a
more rapid clearing of psoriatic plaques at lower doses of both treatment modalities

than either therapy alone. 4 A case report of a patient treated for over 14 years with

PUVA therapy and topical steroids developed 34 SCC in total, 21 of which developed
with PUVA and cyclosporin adjuvant therapy. An inhibition of tumor formation

occurred with the onset of acitretin therapy (60 mg/day) and continuous treatment with
acitretin has kept the patient tumor free for 4 years.

Acitretin may therefore have

some value in preventing the occurrence of SCCs in patients treated with long term

PUVA. As acitretin thins the stratum corneum and epidermis, however, lower doses
of UVB or UVA should be used as there is an increased sensitivity to ultraviolet light

resulting in burning. 42

In summary, review of the current randomized clinical trials, large human
cohort and case-control studies does not illustrate a beneficial effect of either natural
dietary retinoids or synthetic retinoid supplementation for treatment or prevention of

BCCs or SCCs in the general patient population. In contrast to these larger best
evidence studies, several small trials have demonstrated the potential role for oral

retinoids in preventing NMSCs in patients with a higher susceptibility to skin

neoplasms such as patients undergoing concurrent immunosuppressive treatment

15

status post transplantation, patients with xeroderma pigmentosum, or patients being

treated with PUVA therapy for psoriasis. Unfortunately, large cohort and randomized
clinical trials have not yet been published on the relationship between retinoids,

NMSC, and these specific conditions.

Selenium

Selenium is found in fish, shellfish, red meat, egg yolks, chicken, garlic, tuna,

bread, cereal, mushrooms, asparagus and grain products. This trace element is
necessary for the function of the detoxifying enzyme glutathione peroxidase, which

helps to reduce the presence of highly reactive hydroxyl free radicals. It is thought
that these hydroxyl radicals attack DNA and cause mutations. 43 Studies in mice have
shown that increased levels of dietary selenium provide protection against ultraviolet
induced skin tumors. 44 Stewart et al.,

199645 examined whether the combined use of

antioxidant nutrients such as selenium, Vitamin C, and Vitamin E decreased the level

of UVB induced oxidative damage to mouse keratinocytes as indicated by the
formation of the DNA adduct, 8-hydroxydeoxyguanosine (8OHdG). The

investigators’ goal was to determine whether antioxidant supplementation could
enhance the rate of DNA repair of UVB induced lesions. When keratinocytes were
incubated for 2 days with the nutrients a significant decrease in the amount of

oxidative damage was observed, as measured by a decrease in the number of 8OHdG

adducts per pretreated cell. By increasing the concentration of antioxidants in the
culture medium during cell growth there was a significant decrease in the DNA

oxidative damage that occurred as a consequence of UVB irradiation.

16

In human trials, serum selenium levels were found to be predictive of future
cancer risks in humans. 6 A case control study by Clark et al.,

198447 illustrated that

skin cancer patients that were otherwise healthy had significantly lower mean serum

selenium values than did controls. The most powerful study evaluating the effects of

selenium supplementation for cancer prevention in patients with known carcinoma of

the skin was conducted as a large, multicenter, double-blind, randomized, placebocontrolled trial by Clark et al., 1996. 4 The purpose of this study was to determine

whether the incidence of cancer could be decreased with the nutritional

supplementation of selenium. A total of 1312 patients, with a previous history of BCC
or SCC, from selenium deficient areas of the eastern United

States, were randomized

to either an oral selenium supplementation group (200ug/day) or a placebo group and

followed over a 4.5-year period. They found that the selenium treated group did not
have a significantly different incidence of either BCC or SCC. Thus they concluded
that selenium supplementation does not protect against the development of BCCs or

SCCs in the skin. This study did show, however, a 40% reduction in non-cutaneous
cancers in the group receiving selenium. Although the number of cases was small,

treatment with selenium was shown to reduce the incidence of cancers involving the

lung, colon/rectum and prostate as well as reducing the mortality of lung cancer.
Interestingly, breast cancer, bladder cancer, and leukemia-lymphoma were more

frequent in the selenium group than in the placebo group. However, none of these
differences was statistically significant. 4

In conclusion, while oral administration of selenium has been shown to reduce
the incidence of several types of cancer, its direct effect in reducing BCC or SCC

17

incidence has not been demonstrated in human randomized clinical trials to date. The

protective effect of other preparations of selenium such as topical applications has not
been examined in a systematic way and may present a possibility for future studies.

/f-carotene

fl-carotene is available in food sources such as orange and red vegetables,
carrots, tomatoes, beets, and berries. There are more than 600 carotenoids in the food

supply but some of the most common are ]3-carotene, alpha-carotene, lycopene,
crocetin, and fucoxanthin27. In the last decade, studies have attempted to establish a

relationship between NMSC risk and ]3-carotene, the most well studied carotene. 3’49

,/3-carotene has been postulated to reduce free radical damage of DNA after ultraviolet
exposure, s Indeed, mice studies have demonstrated a decrease in the number of
chemically and UV light induced skin cancers as a result of oral supplementation of 13-

carotene.S 1,52
Data in humans showed that oral 13-carotene supplementation reduced
ultraviolet immunosuppression52. However, when Noonan et al., 1996 examined

dietary ]7-carotene and ultraviolet-induced immunosuppression, they were not able to
show that supplementing the diet of mice with oral

3-carotene altered their

susceptibility to UV immune suppression 3. Results of these animal and small human
studies on [-carotene and NMSC have not demonstrated consistent results.

In a large, randomized, placebo-controlled trial, 1805 patients with recent
NMSC were given 50 mg of fl-carotene/day for up to 5 years. 4 Although the median
plasma fl-carotene levels increased to 8.5 times baseline, no significant effect was
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found on the incidence of the first new NMSC. More recently, researchers have
embarked on several large human cohorts and randomized controlled trials examining
the relationship between [3-carotene supplementation and the prevention of BCC and

SCC. Van Dam et al., 200030 examined the role of fat intake, antioxidant nutrients,
retinol, folate and vitamin D as possible preventitive agents against the formation of

BCC in a cohort study of 43,217 men followed over an 8-year time period. At the
onset of the study, the dietary habits of the male subjects were assessed via validated

food frequency questionnaires. Analysis of their data, which related carotene intake
in 1986 to BCC occurrence between 1990 and 1994 revealed that alpha-carotene, was
associated with a slightly lower risk of BCC (i.e., P=0.01 with a 95% confidence
interval and a relative risk of 0.88).

-carotene illustrated a less significant effect, P=

0.03 and a relative risk of 0.81. However, the investigators concluded that, overall,

the findings do not support the hypothesis that diets low in fat or high in specific

200030 study are

vitamins lower the risk of BCC.

The findings of the van Dam et al.

similar to that of the Hunter et al.,

19924 large prospective cohort study in which diet

(vitamins C, D, E and ]3-carotene) and the risk of BCC development was evaluated in
female nurses over a 4 year follow up period with no conclusive results.

Green et al. 1999, 6 in a randomized placebo-controlled trial, examined the
relationship between the use of daily sunscreen application and [3-carotene
supplementation in order to prevent BCCs and SCCs. Using prospective design 1,383

patients were followed over a 4.5-year period. The patients were split into four groups
accordingly: daily sun protection factor 15 sunscreen application and 30mg/day of oral

-carotene; sunscreen plus placebo pills, 30 mg/day of -carotene only; and placebo

19

pills only. Results of this study illustrated that in terms of BCCs there were no
statistically significant differences between the patients who used daily sunscreen and
those who did not. Using daily sunscreen did, however, have a significant effect on

the number of SCCs patients developed in this cohort. There was no significant
difference between the group that took oral fl-carotene vs. placebo pills for both BCC

and SCC.

These findings are consistent with an older placebo-controlled clinical trial

in which 1,805 patients with a previously diagnosed NMSC were given either 50mg of

oral/7-carotene or daily placebo pills over a 5-year period. Neither the total number
of new NMSC nor the time period in which the patients developed a new NMSC was

significantly different between the two groups. 54

In conclusion, a systematic review of the large cohort and randomized clinical
trials illustrates that no chemopreventive effect was demonstrated with either normal

dietary consumption or oral supplementation of [-carotene. ’4’s’6 Although

researchers who argue for the beneficial effects of betacarotene supplementation

suggest that these benefits may only be appreciated over a lifetime of use, this idea is
difficult to examine due to the length of study time that would be required.

Synergy of the Antioxidants on NMSC
Substantial evidence indicates that the antioxidant system of the skin is

interlinked. Review of the current randomized and placebo controlled human trials
reveals that the synergistic use of specific antioxidants proves to be more successful
than with the individual components alone.

fl-carotene in Synergy
The protective effect of oral supplementation with ]3-carotene and vitamin E

against the development of erythema in humans was recently examined alone and in
combination s7. Serum

13-carotene and vitamin E concentrations were found to

increase with oral supplementation. After 12 weeks of treatment with a carotenoid

supplement (25 mg) or carotenoid plus vitamin E (500 IU), the erythema reaction after

UV irradiation was significantly diminished (p<0.01) on dorsal (back) skin. The
authors found that the suppression of erythema was greater when the antioxidants
were used in combination than when the carotenoids were used alone. Weaknesses of

this study include the lack of a placebo group and the absence of blinding of the

investigators to the identity of the experimental groups.
Another proposed mechanism for the prevention of skin cell carcinogenesis is

.

to protect cells from the attack of the free radicals, NO)_ and peroxynitrite anion

(OONO-)

In a study by Bohm et al.,

19985s, human lymphoid cells were taken

before and after patients consumed a 2-week regimen combination of oral ]3-carotene

(150mg/day,), vitamin C (1000mg/day), and vitamin E (ct- tocopherol 800mg/day).
2O
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All cells were then exposed to the free radicals NO2 and OONO-, in sequemial

experiments. Cell staining with eosin was used to show which cells had membrane
destruction leading to cell death. The cells taken from patients after the antioxidant
treatment showed cell staining of 6% while cells taken from patients before
antioxidant treatment had a cell staining of 61.4%. The authors concluded that the use

of [-carotene with vitamins C and E offered synergistic cell protection against both
the NO and OONO- radicals with a greater protective effect against NO2.

Vitamin C and Vitamin E alone and in Synergy

Studies suggest that the topical application of vitamin C combined with
vitamin E offers a more significant photoprotective effect than either agent alone. On a

molecular level, this may be due to the capacity of vitamin C to regenerate vitamin E
from its free radical form. 59’60 This premise has been supported by other

investigations that examined the antioxidant interactions on membrane lipid
oxidation. 6’62 In effect, by combining vitamin C and E, the free radical scavenging

capabilities of each may be extended, thereby increasing the total antioxidant capacity

of the skin.
Vitamin C, or ascorbic acid, is a cofactor for the enzymes that are responsible

for the hydroxylation of proline and lysine in collagen, which helps to stabilize

collagen’s helical structure. 62 The body does not produce this antioxidant; instead it
must be consumed in the form of citrus fruits, strawberries, tomatoes, cantaloupe,

potatoes, and dark green leafy vegetables. Studies by Shindo et al. in 1993 and

199464,65 in murine epidermis and dermis have shown that UV exposure leads to the
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depletion of vitamin C. As a result, the skin appears to be susceptible to damage by
reactive oxygen species. Inasmuch as vitamin C is a known antioxidant, it has been
studied as a therapeutic means to protect the skin against free radical damage.
Porcine studies examining the use of vitamin C as a topical photoprotectant

have shown it to concentrate in the skin while decreasing erythema and UVB

phototoxic damage. 66 Studies in mice have also shown vitamin C to offer a

photoprotective effect against UV induced chronic skin damage. 67
Miyai,

19966 examined the ability of a stable derivative of ascorbic acid,

ascorbic acid 2-O-alpha-glucoside (AA-2G), to induce resistence against UVB cell

injury in a human keratinocyte cell line established from squamous cell carcinoma.
Cells were preincubated in the AA-2G solution, exposed to UVB radiation and then
reincubated in the same solution for 24 hours. Miyai found that the stable ascorbic
acid derivative AA-2G had a significant preventive effect against UVB cellular

damage and this effect had greater significance with increasing concentrations from
0.1 to lmM (p<0.01, p<0.001, p<0.0001) when compared with ascorbic acid or

controls, thereby offering a photoprotective effect against UVB-induced damage in
human epithelial cells.

However, few human double-blind placebo-controlled studies have shown
either topical or oral administration of vitamin C alone to offer photoprotection against

damaging UV radiation. One small study by Murray et al., abstract

1991,69 examined

the effect of UVB radiation on the forearms of 10 human volunteers who were

pretreated with 10% topical vitamin C solution or placebo. The areas of skin that were
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pretreated with the vitamin C solution demonstrated a less intense erythematous
response while demonstrating a significant increase in the minimal erythema dose.
Vitamin E is found in foods such as nuts, vegetable oils, shortening, margarine,

whole grains, olives, asparagus, spinach, and mayonnaise. Vitamin E is the main lipid
soluble antioxidant that has been shown to protect cell membrane lipids from

peroxidation by scavenging free radicals. 6 The topical application of alpha-

tocopherol, the most active form of vitamin E, has been shown to prevent skin cancer
and immunosuppression induced by UVB irradiation in mice. 7 However, alpha-

tocopherol has limited stability at room temperature in comparison with the
thermostable esters of vitamin E, alpha-tocopherol acetate and alpha-tocopherol
succinate 7.

Commercially, the most common form of vitamin E, alpha-tocopherol

acetate, is a popular ingredient added to skin lotions, sunscreens, and cosmetic

preparations. It should be noted that the topical application of the different forms of
vitamin E (including alpha-tocopherol, alpha-tocopherol acetate, alpha-tocopherol

methyl ether, gamma-tocopherol, and delta-tocopherol) has demonstrated varied
results in animal models. For example, mice topically treated with a 1% alpha-

tocopherol and exposed to UVB had 43% less formation of thymine dimers than
controls. Other forms of vitamin E (including alpha-tocopherol acetate, alpha-

tocopherol methyl ether, gamma-tocopherol, and delta-tocopherol) also inhibited DNA
thymine dimer formation but were 5 to 10 fold less potent than alpha-tocopherol. 7

Additionally, Mc Vean et al.,

199972 compared the efficacy of alpha-

tocopherol to other vitamin E compounds (alpha-tocopherol acetate, alpha-tocopherol
methyl ether, gamma- tocopherol, delta- tocopherol) and 3 commercially available
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sunscreens for their ability to inhibit DNA photodamage in mouse skin in vivo. They

found that application of a 5% solution of either alpha-tocopherol, gamma- tocopherol,
or delta- tocopherol each produced a significant inhibition of thymine dimer

formation whereas both alpha-tocopherol acetate and alpha-tocopherol methyl ether
did not. In terms of the commercial sunscreens, only the sunscreen agent

octylmethoxycinnamate inhibited dimer formation while the other two agents tested

(ethylhexyl salicylate and oxybenzone) did not. The incorporation of vitamin E into
sunscreen products confers protection against procarcinogenic DNA photodamage.

However, the specific type of tocopherol appears to be determinate of the magnitude
of the prophylactic effect.

Berton et al.,

19987 studied the effect of alpha-tocopherol acetate,

applied

before or after UV exposure on the inhibition of UV carcinogenesis in the hairless
mouse compared with vehicle controls. They found that mice that received the alpha-

tocopherol acetate preparation had delayed tumor formation and yield for the first 20
weeks of the study but that this effect was lost by week 30. The telomerase activity of
carcinomas in the mice treated with vitamin E was significantly lower than vehicle

controls. Additionally, cyclobutane dimer repair was greater in the alpha-tocopherol
acetate treated groups and tumor suppressor gene p53 expression was maximally

higher after less UV exposure in this group as well. This study therefore supports the

mitigating role of alpha-tocopherol acetate in the initial events of skin carcinogenesis
associated with UV irradiation such as DNA damage. However, it has limited

potential in preventing UV- induced proliferation and tumor formation.
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Gensler,

199670 examined whether the thermostable esters of vitamin E, alpha-

tocopherol acetate and alpha-tocopherol succinate prevented skin cancer or
immunosuppression in mice. They found that neither of the esters significantly

prevented photocarcinogenesis nor prevented the induction by UV radiation of

immunosusceptibility to implanted antigenic UV-induced tumor cells. Additionally,

they noted that at the concentrations of 12.5mg alpha-tocopherol acetate and 25mg of

alpha-tocopherol succinate, photocarcinogenesis was actually enhanced (p=0.0114).
They concluded that these esterified forms (alpha-tocopherol acetate and alpha-

tocopherol succinate) do not prevent carcinogenesis and may actually enhance skin
cancer development and growth in a UVB carcinogenesis mouse model.

Additionally there has been further research into whether Vitamin E in the
form of alpha-tocopherol acetate was converted in human skin to the active and

photoprotective alpha-tocopherol. In a double-blind study, 19 patients >30 years of
age who had a least three actinic kerotoses on their forearms were randomly assigined
to the treatment group (alpha-tocopherol acetate) or vehicle control group. Both

groups applied the creams to their arms twice daily for three months. Blood samples,

photographs, and punch biopsies were taken before the start of the study and after the
study was completed. Plasma and skin concentrations of free alpha-tocopherol and

alpha-tocopherol acetate were calculated. The investigators found that while alpha-

tocopherol acetate was substantially absorbed in the skin, there was no evidence of
cutaneous or systemic conversion to the active alpha-tocopherol form of vitamin E 74

Additionally, the authors surveyed commercially available sunscreens to assess their

alpha tocopherol content and found that of 191 sunscreens sampled, 119 (62%)
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contained some form of alpha-tocopherol, 69 (36%) contained no alpha-tocopherol,
and only three (2%) disclosed the active ingredients.

In light of the Gensler,

199670 and the Alberts et al. 199674 studies, it is evident

that alpha-tocopherol acetate, the most commercially available form of topical vitamin

E, confers less photoprotective effects in mice models than other forms of vitamin E
such as alpha-tocopherol and may even promote carcinogenesis. Additionally, alpha-

tocopherol acetate is substantially absorbed in the skin and is not converted to its
active form. These findings underscore the importance of determining which forms of
vitamin E inhibit the UV induced lesions involved in photocarcinogenesis and which

may actually lead to cancer formation.

Similarly to topical vitamin E, the potencies of several forms of oral vitamin E
vary as well. Dosage is therefore usually expressed in terms of international units

(IU), based on terms of activity. For example, I mg d-alpha tocopherol- 1.49 IU. In
humans, a small double-blind placebo-controlled study of 12 patients given oral
vitamin E (not otherwise specified) 400 IU/day for 6 months was not shown to reduce

the MED or the number of sunburn cells when the treatment group was compared to
controls. 7s Additionally, Vural,

199976 investigated whether levels of certain plasma

*antioxidant alpha-tocopherol, ascorbic acid, total thiol groups, ceruloplasmin, urate,

albumin, and erythrocyte glutathione, were altered in patients with actinic kerotoses

(AKs) or BCCs. Plasma samples from 13 patient with AKs, 12 patients with BCCs
and 16 healthy controls were compared. Plasma levels of ascorbic acid (p<0.001),

alpha-tocopherol (p<0.05) and RBC glutathione (p<0.05) were significamly lower in
patients with AKs and BCCs. The investigators suggested that plasma levels of

27
certain antioxidants were decreased in patients with AKs or BCCs due to the long

exposure of UV irradiation.

In a double-blind placebo- controlled study, Eberlein-Konig et al.,

199877

assessed the photoprotective effect of systemic vitamins C and E in humans. Ten

subjects were randomly assigned to the vitamin group and given daily doses of
vitamin C (ascorbic acid 2g) and Vitamin E (d-alpha-tocopherol 1000 IU) for 8 days,
while the other randomly assigned ten subjects, matched to the first group by skin

type, were given the placebo. The sunburn reaction was assessed by determining the

MED and by measuring cutaneous blood flow of irradiated skin and nonirradiated skin
before and after administration of the oral vitamins or the placebo. The results of the

study illustrated that the patients given the oral vitamin combination had significant
increase in their MED (p<0.01) vs. patients in the placebo group. Cutaneous blood

flow was significantly decreased in the treatment group, whereas it was increased in
the placebo group (p<0.05). The authors concluded that the combined use of oral
vitamin C and vitamin E created a synergistic effect to reduce sunburn reactions

significantly.

A second prospective, randomized and placebo controlled human trial by
Fuchs and Kern,

19987 examined whether oral supplementation with vitamin E (d-

alpha-tocopherol) and vitamin C (L-ascorbic acid) alone or in combination influenced
the UV radiation induced skin inflammation in volunteers before and 50 days after

supplementation. A dose-response curve of UV induced erythema was generated and
the MED was determined by visual grading before and after supplementation. The
dose response curve showed a significant flattening while the MED showed a
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significant increase for the group that received combined antioxidant therapy as

opposed to the groups that received either the vitamins alone or the placebo. The
authors concluded that the antioxidant vitamins E and C acted synergistically in the

suppression of the sunburn reaction.
Dreher et al. 1998 s9 recently investigated the possible photoprotective effect
achieved when topical vitamin C, vitamin E, and melatonin were combined in a small

randomized, double-blind human study. Twelve patients of Fitzpatrick skin type II or

III were selected and all patients served as their own respective controls. All patients
received combinations of the antioxidant mixtures and vehicle controls, which were

applied to the lower backs of the patients in a randomized double-blind manner.

Thirty minutes after treatment, all patients were subjected to UV radiation and their

response was measured in terms of Frosch and Kligman (1979) 79 erythema scale. The
authors found that the topical application of the hormone melatonin alone resulted in a

dose-dependent inhibition of the erythema formation. The use of vitamin C or E alone
had only a slight effect on the amount of erythema demonstrated by the patients. The
combination of vitamin C and E showed a more prominent effect in erythema

prevention while the combination of vitamin C, E, and melatonin had a significant

inhibitory effect on erythema.

In conclusion, the skin has an endogenous complex antioxidant defense
system that scavenges reactive oxygen species and combats UV-induced oxidative
skin damage. This defense system, however, can become overwhelmed with

excessive UV exposure, which leads to cutaneous UV damage, premature aging and
skin cancer, s Supporting the naturally occurring antioxidant system of the skin via
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delivery of antioxidants either topically or orally may be a successful strategy for

photoprotection.

Effects of Fat Intake on NMSC

Black and colleagues,19948 studied the relationship between fat intake and the

development of actinic keratoses (AKs) and NMSC. In an initial randomized clinical
trial 76 patients with a history of NMSC were asked to eat their regular diets (control

group) or a modified diet with 20% of their total calories derived from fat (the
experimental group). 8 For a total of 24 months the patients were examined by a
physician, blinded to the designation of the study groups, for the development of
actinic keratoses. At four months of dietary intervention the control group maintained
their fat intake at 40% of their total calories while the experimental group had lowered

their fat intake to 20% of their total calories. The total number of AKs per patient
over the study period was significantly fewer in the experimental group than in the

control group.

A further clinical trial by Black et al.

199882 involving 115 patients who were

randomly assigned to either the control or experimental group examined the
relationship between a low fat diet and the prevention of actinic keratoses and NMSC
over a two-year period. In this study the patients in the experimental group were

educated in detail regarding dietary changes in order to reduce their fat intake to 20%
of their total calories and maintain this change over the entire two-year period. The
results of this study were similar to the Black et al., 1994 study, in that there was a

significant decrease in the skin cancer occurrence of the experimental group as

compared with controls (p<0.01). The cumulative numbers of new AKs per patient
over the 2 years was significantly (p<0.001) fewer in the experimental group than in
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the control group. There were no significant changes in the numbers of NMSC skin
cancers per patient in the control group over the 2-year period.

However, in the

experimental group the numbers of NMSC decreased significantly over the last 8
months of the study (p<0.02). The authors did not postulate a specific reason for this

interesting finding in the study’s final 8 months instead of at earlier time periods

during the study.

Herbal and Alternative Therapies for NMSC

Anticarcinogenic Effects of Tea

Chemoprevention by means of phytochemicals has been the focus of many
cancer prevention studies within the last decade. In many cultures, the most popular

beverage in the world, next to water, is tea. Many animal organ specific studies have
shown that certain components of tea offer anti-carcinogenic properties.

These

constituents are known as polyphenols, which serve as antioxidants to prevent
oxidative damage induced by free radicals. 83 Studies have focused on the phytogenic

properties of green tea polyphenolic (GTPs) antioxidants and have recently been
reviewed in Katiyar et al., 2000. 84 The major and most preventive ingredient thought
to confer the cancer chemopreventive properties of green tea is known as

(-)-epigallocatechin-3-gallate (EGCG). 8
There are increasing amounts of experimental evidence both in animal and
human studies that indicate that both topical and systemic extracts of green and black
tea can inhibit carcinogenesis. 86 Animal studies have shown both chemically and UV

induced cutaneous carcinogenesis has been inhibited by the phytochemicals available

in tea. 87’88 Agarwal et al. 1992 89 studied the effect of topical application of EGCG to

the skin of SENCAR mice pretreated with TPA, a tumor promoter. They found that
there was a dose-dependant reduction in epidermal inhibition of ornithine

decarboxylase, an enzyme responsible for clonal expansion of skin tumors. Studies
involving black tea polyphenols have elicited similar results in the inhibition of the
tumor promoter TPA. 9 Green tea polyphenols (GTP), applied to DMBA/TPA
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induced cutaneous papillomas have been shown to inhibit the conversion of benign

neoplasms to malignancies in SENCAR mice. Mice with pre-existing papillomas
were exposed to additional free radical generating compounds such as benzoyl

peroxide or 4-nitroquinoline-N-oxide to initiate a malignant conversion. The
formation of squamous cell carcinomas from papillomas was significantly reduced

with administration of GTP 30 minutes prior to application of the free radical

generating compounds. 9

In an in vivo study by Gensler et al.

199692, topical EGCG was applied 3 times

per week to BALB/cAnNHsd mice in doses of 0mg, 10mg, or 50mg for 28 weeks
while they concurrently received 2. lx 10 6 J/m2 of UVB light 5 times per week. The

incidence, multiplicity and volume of UV-induced skin tumors were significantly
reduced in a dose dependant manner in these animals.
The protective effect of topically applied GTP against UV induced erythema
has been studied in human volunteers by Mukhtar et al., 1996. 93 Different
concentrations of green tea polyphenol preparations, as well as a placebo dose, were

applied to the backs of volunteers who were then subjected to UV radiation at twice
the minimal erythema dose (MED). Sites that were pretreated with the GTP solutions
exhibited significantly less erythema than the controls. The photoprotective effect of

GTP was dependent on the strength of the dose applied with the most effective

protection seen at dose of 200/al of a 5% solution.

A significant protective effect against MED enhancement of sunburn cell
formation was also reported. A more recent human study by Katiyar et al.,

199994

examined whether topical treatment with EGCG would offer protection against UVB-
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induced infiltration of leukocytes, a possible source of oxygen radical generation and

prostaglandin metabolites which have been shown to play a prominent role in skin
carcinogenesis. The authors found that application of topical EGCG prior to UVB

exposure significantly blocked the infiltration of leukocytes, led to decreased

erythema, and produced fewer intlammatory prostaglandin metabolites. Additionally,
the topical application of GTPs before UVB exposure of human skin led to a

decreased formation of cyclobutane pyrimidine dimers in DNA, which have been

implicated as initiators in the process of UV induced mutagenesis and
carcinogenesis. 84,94

As described above, there is much animal and human evidence pointing to the
use of tea as a phytogen to help to boost the endogenous antioxidant defense system of

the skin. Randomized clinical placebo-controlled trials on human subjects are now

required to evaluate the efficacy of naturally occurring polyphenols found in tea.

Current Phase I Clinical Trials are now underway at M.D. Anderson Cancer Center
and Memorial Sloan-Kettering Cancer Center on the therapeutic effect of green tea on
advanced solid tumors. 8

Other Herbal and Alternative Treatments for NMSC

A myriad of small studies examining the relationship between herbal and
alternative remedies for the treatment and prevention of NMSC have been published
in the oncology literature and are summarized in table 1.
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Table 1. Herbal and alternative remedies for the treatment and prevention of
Study
Seed or
Herb
1
Hibatallah
et al.,

Active

NMSC.
Experimental

Mechanism

Ingredient

Milieu

of Action

In vitro and In
(human
models)

Gingko biloba

Ginkgo

33% extract of

biloba

Gingko flavone
gycosides

vivo

199995

is 24%

flavenoids,
which has the
properties of a
free radical

scavenger
similar to
superoxide
dismutase.

2 Lin &

Ginkgo

Chang,

biloba

199796

Ginkgo biloba
Extract in 50%
alcohol

In vivo (mouse
models)

Locally induce
superoxide
dismutase and
catalase

enzyme
activity in
epidermis of
3 Guevara
et al.

199997

Seeds of
the
Philippin
e PlantMoringa
oleifera

Niazimicin

In vivo (mouse
models)

rats
Mechanism not

specified

Findings

Ginkgo extract
significantly
inhibited the
cutaneous
blood flow by
37% (which
reflects the
skin

inflammatory

level)
Ginkgo biloba
pre-treated
skin showed
significant
protection
against UVB

damage
Niazimicin has
a potent
antitumor

promoting
activity against
the two stage

Lain

mouse tumor

"Horse

carcinogenesis

radish"

model (DMBA
as a tumor
initiator and
TPA as a
tumor

4 Keum et

al., 200098

Ginseng

Methanol extract
of heat-

processed
ginseng

In vivo (mouse
models)

TPA-induced
enhancement

of epidermal
ornithine

decarboxyase
activity and
mRNA
expression was
abolished

promoter)
Significantly
decreases the
formation of
skin

papillomas
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5
Srivastava

& Shukla,

199899

Cruciferous

Indole-3-carbinol

vegetables:
cabbage,
cauliflower,
and brussel
sprouts

In vivo (mouse
models)

A single dose of
the tumor
initiator DMBA,
followed by the
tumor promoter,
TPA twice per
week. Half of
the mice
received 250 ug
indole-3carbinol.

Tumor
development
was

significantly
inhibited in
indole-3carbinol-

supplemented
animals in
terms of
cumulative

numbers of
tumors and

average
tumors per
mouse. 44%
of the male
mice and 29%
of female mice
remained
tumor free by
the end of the

experiment. A
significant
delay in tumor
induction time
was also
observed in

indole-3carbinol

supplemented
animals
6

Yasukawa,

19981

Rice bran

Cycloartenol
ferulate

In vivo (mouse
model)

Pharmacological
activities of the
ferulate
components of
rice bran
include:

improves
peripheral blood
flow, possesses
anti-

inflammatory
effect, possesses
anti-tumor

promoting effect

Dose
dependant
inhibition of
DMBA/TPA
tumor

induction and
inflammation
in mice
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7
Ichihashi,
2000 TM

Extra
virgin

Extra virgin
olive oil

In vivo (mouse
model)

olive oil

8 Zhao et

Grape

al.,

seeds

199912

Grape seed
polyphenols
(GSP)

Possibly by
decreasing
reactive oxygen
species induced

8-OhdG, which
is responsible
for gene
mutation

exposure
significantly
delayed the onset
and reduced the
number of skin
cancers. 8-OHdG

The

formation in mice
was inhibited
The observed anti-

In vitro
SENCAR

polyphenols

mouse skin

isolated

significantly
inhibited

epidermal lipid
peroxidation

9 Gensler
et al.,

199913

Niacin

Vitamin B3

Olive oil painted on
the skin after UVB

In vivo mouse

Niacin

model

supplementation
elevated skin
NAD content,
which is known
to modulate the
function of
DNA strand
scission
surveillance

proteins p53
and poly(ADP-

ribose)
polymerase, two
proteins critical
in cellular

responses to
UV-induced

DNA damage.

tumor-promoting
effects of GSP were
dose dependent and
resulted in a
reduction of tumor
incidence,
multiplicity and
volume

A do’se-dependent
preventive effect of
oral niacin on
photocarcinogenesis
and photoimmunosuppression
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10 Huang
et al.,

Rosemary

Carnusol/ursolic

In vivo mouse

acid

model

Not specified

1994 TM

Topically
applied
rosemary
inhibits skin
tumor
initiation by

DMBA, tumor
promotion by

TPA
11
Limtrakul
et al.,

The pl’nt

Curcuma
longa

199755

Curcumin, the
yellow pigment
used as a spice

In vivo mouse

Curcumin is a

model

phenolic
compound
possessing

and food
coloring agent

anti-

inflammatory
and antioxidant

12 LahiriChatterjee
et al.,

1999506

Milk
Thistle

The flavonoid
Silymarin

SENCAR mouse
model

Dietary
administration
of curcumin
significantly
inhibited the
number of
tumors per
mouse

properties that
inhibit DMBA
initiated TPA-

the tumor
volume

induced

(p<0.01)

(p<0.05) and

epidermal
DNA
synthesis.
Highly
significant
dosedependent

to
DMBA/TPA

inhibition of
tumor DNA

significantly
reduced tumor

synthesis and
lipid
peroxidation

(p<0.001),

Application of
silymarin prior

incidence
tumor

multiplicity
(p<0.001) and
tumor volume

(p<0.001)

Melanoma Sn Cancer

Evidence supports the concept that UV radiation induces DNA damage that

leads to melanoma in both animal and human skin. 7 For example, patients with
xeroderma pigmentosum have a decreased ability to repair DNA damage caused by

UV radiation and have a greater risk of developing both melanoma and non-melanoma
skin cancer. Additionally, it was recently shown that melanoma could be induced via

UV radiation exposure on human skin in an experiment conducted with human skin
xenographically attached to immunologically naive mice. 8 The incidence of
melanoma skin cancer increases exponentially with age. 09 The opport.Nnities for the

generation of tumors over time are increased in addition to the decrease in the ability
to repair DNA.

0

UVB radiation is significantly responsible for the formation of the main DNA
lesions and also the formation of photoproducts such as cyclobutane pyrimidine

dimers and pyrrimidine (6-4) pyrimidone photoproducts. 7 The incorrect repair of

these principal DNA lesions leads to mutations. A significant contributor to the
formation of melanoma is intense intermittent exposure to UV radiation 7. In

accordance with this hypothesis, although melanoma can occur at any location on the

body, it most commonly affects areas of intermittent sun exposure such as the upper
backs of men and the lower legs of women. 107,110,Ill

Melanocytes, unlike keratinocytes, do not experience the same level of

apoptotic screening. Although a first high dose of UV radiation will cause significant
damage to melanocytes, they are much more likely to mutate and survive than
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keratinocytes. 7 In contrast, after prolonged UV exposure, the most severely

damaged keratinocytes undergo apoptosis, leaving the less damaged keratinocytes to

up-regulate DNA repair capacity and restore themselves back to their baseline. With
each continued exposure the most damaged cells are removed and the cells with only
minimal damage remain. It has been previously illustrated that these sub-lethal hits to

the DNA of keratinocytes actually promote the DNA repair mechanisms of the
cells. 5,1

Phytochemicals for MM Prevention
Mice studies have examined a variety of dietary supplements that may prove to

be helpful in the prevention of cutaneous melanoma and the metastasis of melanoma.

Plant estrogens or phytoestrogens have been investigated for their anticancer effects.

Recently, Li et al. 1999

looked at the importance of lignans, a group of

phytoestrogens, which are converted in humans to enterodiol and enterolactone by the
action of the bowel microflora. Lignan precursors are found in oilseeds, whole grains,

legumes and certain vegetables, but flaxseed is the richest source.

Evaluation of the

effect of dietary supplementation with a flaxseed derivative known as
secoisolariciresinol diglycoside (SDG) on the metastasis of melanoma in mice

demonstrated a reduction in the volume and number of pulmonary melanoma
metastases as compared to the control group (P< 0.01). 13

Studies of the murine melanoma cell line B 16 and specific phytochemicals

have illustrated a tumor growth-suppressive effect. Mo and Elson 1999

the relationship between the isoprenoids,

14

examined

fl-Ionone (a cyclic analog of 13-carotene) and
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gamma- tocotrienol (a less potent form of vitamin E) isolated from rice bran oil on the
murine melanoma B 16 cell line. They found that the addition of fl-ionone and

gamma-tocotrienol to the tumor cell lines led to a 23% inhibition in growth (p<0.001
for 15umol/L) and a 56% inhibition in growth (p<0.001 for 150umol/L) of the
melanoma cells, respectively. The study also illustrated a synergistic and additive

growth-suppressive action on the melanoma cells when these phytochemicals were
combined. TM

Vitamin D

Vitamin D is found in fortified milk, fish (herring, mackerel, salmon, sardines,

shrimp, tuna, cod), fish oil, and is also produced in the skin by UV induced conversion
of previtamin D. Vitamin D is then hydroxylated in the liver and kidney respectively
to its most active form 1,25-dihydroxyvitamin D3

(VD3). This active steroid hormone

binds to the vitamin D receptor (VDR) to exert its actions, including calcium

homeostasis.

VDR has also been detected in certain cancer cell lines including

melanoma. 16 A panel of eight human melanoma cell line was assessed for the level
of VDR expression and the growth inhibitory effects of VD3 by Evans et al. 1996. 115

VDR expression was illustrated in the various melanoma cell lines. Furthermore,
VD3 was a significant (P<0.05) melanoma growth inhibitor in cells with a high
concentration of the VDR receptor. The authors concluded that melanoma cell growth
inhibition might be mediated through the VDR receptor concentration.

Additionally, the role of VD3 and its derivatives on the induction of

programmed cell death, or apoptosis, for human melanoma cells has been examined
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by Danielsson et al., 1998.

17

VD3 has been shown to induce apoptosis in human

breast cancer and leukemic cell lines, l8 In spite of the fact that VD3 has therapeutic

potential, its side effects such as hypercalcemia, hypercalciuria and soft tissue
calcification make it impractical to use clinically. 117,119 VD3 analogs with molecular
modifications have therefore been created. The VD3 analog CB 1093 has been
examined as a future treatment against specific types of melanoma inasmuch as it was

previously found to induce apoptosis of rat mammary tumors in vivo at a lower
concentration than other VD3 analogs with fewer calcemic side effects.

Danielsson

et al., 1998 7 reported that in the early melanoma stage cell line WM1341 apoptosis
was induced by CB 1093 up to twentyfold after 5 days of treatment at a tenfold lower

concentration than the natural hormone (VD3). In contrast, CB 1093 was not effective

against the advanced stage MeWo melanoma cell line. In conclusion, the 1,25-

dihydroxyvitamin D3 analog, CB 1093, may serve as a promising therapeutic
intervention for in vivo regression of ihe early stages of melanoma without the severe
calcemic side effects of its natural vitamin D counterpart.

In further studies, the role of vitamin D and select retinoids on the induction
of apoptosis of human melanoma cells has been examined by Danielsson et al.,

1999. 2 The combined treatment of Vitamin D3 with the select retinoid receptor

ligand CD437 resulted in a synergistic induction of apoptosis for the specific human
melanoma cell line WM1341. In contrast, combination therapy did not induce

apoptosis in the MeWo cell line. The authors concluded that each type of melanoma
cell line has an individual response to combined treatment with vitamin D and select
retinoids.
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Reactive Oxygen Species

As previously discussed, the delicate balance between free-radical generation
and free radical scavenging systems is monitored by the skin’s endogenous defense

system which combats free radical induced cellular damage and death. An imbalance
in antioxidant levels was found in certain cultures of melanoma cells and normal

melanocytes from patients with melanoma TM This disequilibrium included higher
levels of polyunsaturated fatty acids, a decreased level of catalase activity, and
increased concentrations of superoxide dismutase and vitamin E in cells from

melanoma patients.

In a recent study by Grammatico et al., 1998 2, the intracellular levels of
catalase, superoxide dismutase, and vitamin E in normal melanocytes from 11 patients
with melanoma were compared with normal melanocytes from 11 controls. The

percentage of unsaturated fatty acids of cell membranes after exposure to a

peroxidizing agent was measured as a means of determining the amount of free radical

lipid peroxidation damage. A significant decrease (P<0.001) in the catalase level was
associated with an increase in the vitamin E concentration in 5 out of the 11 cultures

from melanoma patients as compared with the controls. No significant change of

superoxide dismutase activity was found. The percentage of unsaturated fatty acids of
cell membrane peroxidation was affected by the ratio of superoxide dismutase to
catalase and increased in melanocytes from melanoma patients vs. controls. The
authors concluded that an imbalance in the free radical scavenging system of the skin
could be present in normal melanocytes from melanoma patients and this may be the
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reason for the increased susceptibility to pro-oxidizing agents such as reactive oxygen

species.

Dietary Supplements

The relationship between diet and the risk of developing melanoma has been
examined in human case-control studies over the last decade. For example, a study

conducted at the Massachusetts General Hospital included 165 melanoma patients and
209 controls. Both populations were controlled for age, hair and eye color, and family

history of melanoma. No significant associations were found between the total
amount of vitamin D intake from food, supplements or milk and the risk of developing

melanoma in the case versus control populations. 3

Kirkpatrick et al. 1994 24 assessed intakes of vitamin A, dietary antioxidants,
and other dietary nutrients and their relationship to the risk of developing melanoma in
a case-control study. Patients with a history of melanoma were randomly selected

from the Seattle-Puget Sound cancer registry and 234 cases were matched to 248

controls for age, sex, and county. All subjects completed a telephone interview and
mailed in food questionnaires in which they were asked to estimate their food intake 7

years prior to diagnosis for melanoma patients and a similar time period for controls.

They found that the level of vitamin E obtained from food was inversely related to the
risk of developing melanoma at an age, education, and energy intake adjusted odds
ratio (OR 0.34, and P=0.01). Additionally, zinc from food supplements was

associated with a decreased risk of melanoma (OR=0.46, and P=0.01). There were no
correlations found with the levels of vitamin A, retinoids, carotenoids and the risk of
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melanoma. There was also no increase in the risk of developing melanoma with
increased alcohol or polyunsaturated fat consumption. In contrast, body mass index
was significantly related to melanoma risk as melanoma patients were more obese

than controls after both populations were age, sex and education adjusted (OR= 1.90,
and P=0.02). The authors point out the important confounders of this study including
a possible recall bias of the cases who may have been hypervigilant in recalling their

diets previous to diagnoses of their respective melanomas. In addition, the validity of
a food questionnaire is always a concern in epidemiological studies; however, other

researchers have substantiated dietary questionnaires of this type. 124 These findings
were similar to the Stryker et al., 1990

case-control study of 204 melanoma patients

compared with 248 controls in terms of the plasma levels of retinol, vitamin E, and Bcarotene and the lack of correlation of melanoma. However, the Stryker et al., 1990

study found a significant correlation between the amount of alcohol consumed and the
risk of developing melanoma (OR=l.8, 95% confidence interval and P=0.03).

Another case-control study examining the correlation between prediagnostic
serum levels of retinol, B-carotene, vitamin E, and selenium and the subsequent risk of

developing melanoma was conducted by Breslow et al., 1995. 26 Serum retinol, Bcarotene, vitamin E, and selenium were assayed to determine the concentration of

these nutrients in case and control samples. Results showed no significant differences
in the serum concentration between the cases or controls. No beneficial influence of
serum nutrients was elicited on the risk of developing melanoma.

The dietary factors and the risk of developing melanoma have also been

studied in a prospective large human cohort study on 50,757 Norwegian men and
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women. 127 All patients in the study completed self-administered dietary questionnaires

previously tested for their validity and reproducibility. The questionnaire did not
focus on the intake of nutrients such as carotenoids, retinoids or vitamin C or E, hence
no broad range of vegetables or fruits were taken into account. The study focused

more on foods such as milk, potatoes, bread, jam, cheese, meat, fats on bread, fats in

cooking, fish, cakes, eggs, oranges, porridge, cod liver oil and vitamin pills.

27

They

found that over the study period from 1977 to 1992, 108 cases of cutaneous melanoma
were identified. Of the 47 cases found in men, most were found on the trunk,

whereas of the 67

cases found in women, most were on the lower limbs.

This study

found a higher incidence of the development of melanoma in women who had a higher
intake of polyunsaturated fats and cod liver oil supplements. The intake of caffeine

for women was inversely related to the development of melanoma. There were no

significant correlations for the men in the study. As the authors point out, the

strengths of this study are the high number of participants, the high response rates of
the participants and the prospective design including thorough follow-up. The results
were somewhat surprising as cod-liver oil is high in omega-3 fatty acids, which have

been previously linked to the inhibition of UV-carcinogenesis, the decreased risk of

lung cancer, and a protective effect against breast and colon cancer. 2’9’3 It should
be noted, however, that no other study has examined the relationship of cod liver oil to

melanoma.

In agreement with the Veierod et al.,1997 7 study, one Danish case-control
study illustrated a decreased incidence of melanoma with increased coffee intake. TM
Other studies examining this relationship have not concurred with these results. 32’33
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Similar discrepancies exist among studies examining the relationship between

melanoma and polyunsaturated fats. 134,135,136

Discussion

Primary and secondary prevention of skin cancer remain two essential ways to

curb the increasing incidence of skin cancer in our population. Physical examination

of the skin and biopsy of all suspicious lesions is still the mainstay of decreasing the

morbidity and mortality of skin cancer.
Of note, in the last decade, the patient population has shown an increased
interest in the use of dietary supplements such as vitamins and herbal preparations to

attempt to prevent cancer. In a recent mail survey of 1,035 people, 40% of

respondents reported the use of some form of alternative health care during the prior
year. 6 Of the four alternative treatments most commonly used, dietary changes or

changes in "lifestyle diet" were the second most frequently reported. 6
Public health advocates need evidence-based information about the effects of

dietary intake and topical applications of antioxidants, vitamins, and herbal remedies
in order to make sound treatment decisions for the care of their patients. In terms of

NMSC, review of recent randomized clinical trials, large human cohort studies, and
case-control studies does not substantiate a beneficial effect for either natural dietary
retinoids or synthetic retinoid supplementation for treatment or prevention of BCCs or

SCCs in the general population. Select populations with defective DNA repair
mechanisms, immunosuppression, or psoriasis receiving PUVA have been shown to

significantly benefit from systemic retinoid treatments. Additionally, while oral
administration of selenium has shown promise for reducing the incidence of several

types of cancer, its direct effect in reducing BCC or SCC incidence has not been
48
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demonstrated. No protective effect for NMSC was achieved with either normal
dietary consumption or oral supplementation of -carotene23’47’4g’49.

However, substantial evidence indicates that the cutaneous antioxidant system
is both synergistic and mulifactorial. Review of the current randomized human
clinical trials reveals that the synergistic use of specific antioxidants proves to be more

successful than with the individual components alone. The use of [3-carotene with
vitamins C and E offered synergistic cell protection against both the NO2 and OONO-

radicals s In a double-blind placebo-controlled study, the combined use of oral
vitamin E (d-alpha-tocopherol) and vitamin C (L-ascorbic acid) created a synergistic

effect to reduce sunburn reactions significantly s’7’7 In summary, the skin has an

endogenous complex antioxidant defense system which can become overwhelmed.
Delivery of antioxidants in combination may serve as a successful strategy for

enhancing the natural antioxidant system of the skin.

The most commercially available form of an antioxidant may not necessarily
be the best form for the treatment of patients. This fact has been highlighted by the

Gensler, 1 99663 and the Alberts et al., 1 99667 studies which emphasize the importance
of determining which forms of vitamin E can inhibit photocarcinogenesis and which
forms may actually lead to cancer formation. Moreover, in order to gain the

photoprotective benefits from vitamin C, it is essential that the type of ascorbic acid
used must be able to penetrate the skin and deliver L-ascorbic acid. Patients should

be advised that many cosmetic vitamin C based products available in the commercial
market contain ineffective derivatives and analogs of ascorbic acid. 153
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In terms of herbal remedies for NMSC, the phytogens available in tea have
been shown to help boost the endogenous antioxidant defense system of the skin in in
vitro mouse and human cell lines and in in vivo mouse models.

However, randomized

clinical placebo-controlled trials on human subjects are required to evaluate the

efficacy of the naturally occurring polyphenols. Also, many single studies in mice and

humans have elaborated potential new antioxidants for the treatment and prevention of

NMSC including ginkgo biloba, ginseng, horseradish, rosemary, and milk thistle.
Results from human case-control and large cohort studies examining dietary
intake or vitamin supplementation for the treatment and prevention of melanoma have
not been consistent.

In studies with specific melanoma cell lines there appears to be

promise for the 1,25-dihydroxyvitamin D3 analog, CB 1093, as a therapeutic
intervention for in vivo regression of the early stages of melanoma without the severe
calcemic side effects of its natural vitamin D counterpart

0.

Conclusion

The increasing incidence of skin cancer in our population has reached

epidemic proportions and has highlighted the need for public health awareness and
intervention. Methods to curtail the rise of skin cancer in the US include the use of

natural alternatives to prevent and treat NMSC and MM. The effectiveness of these
alternative therapies may be supported with further human randomized clinical trails

providing an evidence-based approach toward improving the health of our population.

In this paper, the use of dietary interventions and herbal remedies relating to
the treatment and prevention of skin cancer has been discussed. For the general

population, the natural or synthetic dietary retinoids, selenium or [3-carotene do not
seem to be a clinically protective against NMSC. Current clinical trials reveal that the

synergistic use of specific antioxidants has greater efficacy than the use of individual
components alone.-

In terms of herbal remedies for NMSC, the active herbal extractions available
in tea, ginkgo biloba, ginseng, horseradish, rosemary, and milk thistle have not yet

been shown to be effective for humans

Dietary intake or dietary supplementation for the treatment and prevention of

melanoma, the vitamin D analog, CB 1093 may have promise as a therapeutic
intervention.
Enthusiasm for the use of dietary derived modalities for the treatment and

prevention of skin cancer and is shared by physicians, patients, and the pharmaceutical
industries but needs to be supported by further evidence based studies.
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